US Patent Issued to ALTO NEUROSCIENCE on Jan. 28 for "Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent" (California Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,096, issued on Jan. 28, was assigned to ALTO NEUROSCIENCE INC. (Mountain View, Calif.).

"Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent" was invented by Amit Etkin (Los Altos, Calif.), Wei Wu (Los Altos, Calif.), Chao Wang (Los Altos, Calif.), Nicholas Cooper (Los Altos, Calif.), Joshua Jordan (Los Altos, Calif.) and Adam Savitz (Los Altos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to the use of (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone (NSI-189) or a pharmaceutically accepta...